Biotechnology - UK

Filter

Current filters:

UK

Popular Filters

1 to 25 of 56 results

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

20-08-2014

UK drugs watch dog the National Institute for Health and Care Excellence (NICE) has issued final draft…

BiotechnologyCelgene Corp.Myelodysplastic syndromesOncologyPricingRegulationRevlimidUK

Oxford BioMedica appoints former Aeterna Zentaris senior vice president Paul Blake as chief development officer

Oxford BioMedica appoints former Aeterna Zentaris senior vice president Paul Blake as chief development officer

15-08-2014

British gene and cell therapy company Oxford BioMedica has appointed Paul Blake as chief development…

BiotechnologyBoardroomOxford BioMedicaPaul BlakeUK

Positive draft guidance for hep C drug Sovaldi from UK’s NICE

Positive draft guidance for hep C drug Sovaldi from UK’s NICE

15-08-2014

In further draft guidance published today, UK drugs watchdog the National Institute for Health and Care…

Anti-viralsBiotechnologyGilead SciencesHepatitis CPricingRegulationRibavirinSovaldiUK

UK aims to become world number one in DNA testing with new investment

UK aims to become world number one in DNA testing with new investment

01-08-2014

David Cameron, the UK Prime Minister, has announced a package of investment worth more than £300 million…

BiotechnologyDavid CameronGeneticsIlluminaMedical Research CouncilResearchUK

Life Sciences Hub launched in Wales to support industry

Life Sciences Hub launched in Wales to support industry

17-07-2014

The Welsh Government has today launched the Life Sciences Hub Wales, a national and international focal…

BiotechnologyResearchUKWales

Immunocore and Eli Lilly sign $25 million collaboration

Immunocore and Eli Lilly sign $25 million collaboration

16-07-2014

UK-based biotech firm Immunocore and US drug major Eli Lilly today announced they have entered into a…

BiotechnologyEli LillyImmunocoreImmunologyLicensingLillyOncologyUKUSA

AstraZeneca licensing deal validates Synairgen’s approach, say analysts

AstraZeneca licensing deal validates Synairgen’s approach, say analysts

14-07-2014

Anglo-Swedish drug major AstraZeneca’s recent $230 million deal with British respiratory drug development…

AsthmaAstraZenecaBiotechnologyInterferonLicensingRespiratory and PulmonaryRespiratory therapySNG001SynairgenUK

NICE issues positive draft FAD guidance on Tecfidera

NICE issues positive draft FAD guidance on Tecfidera

11-07-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

Biogen IdecBiotechnologyMultiple sclerosisNeurologicalPricingRegulationTecfideraUK

Oxford BioTherapeutics appoints Eugen Leo as head of clinical development

Oxford BioTherapeutics appoints Eugen Leo as head of clinical development

11-07-2014

UK-based biotech company Oxford BioTherapeutics, focusing on antibody-drug conjugates in the treatment…

BiotechnologyBoardroomOxford BioTherapeuticsUK

Northeast England gets $34 million investment to fund biotechnology facility

Northeast England gets $34 million investment to fund biotechnology facility

10-07-2014

The Centre for Process Innovation has announced investment of £20 million ($34 million) to fund a ‘Biologics…

BiotechnologyCentre for Process InnovationCounty DurhamCPIHealthcareNational Biologics Manufacturing CentreUK

SMC guidance on AstraZeneca’s diabetes drug and Roche’s MabThera

SMC guidance on AstraZeneca’s diabetes drug and Roche’s MabThera

08-07-2014

The Scottish Medicines Consortium (SMC) has issued guidance on Anglo-Swedish drug major AstraZeneca’s…

AstraZenecaBiotechnologydapagliflozinDiabetesMabTheraOncologyRocheUK

Biotech clusters with patent strategies are more attractive to big pharma

Biotech clusters with patent strategies are more attractive to big pharma

01-07-2014

Life sciences and biotech research clusters across the UK are benefiting from an improved funding climate…

BiotechnologyFinancialPatentsUK

UK biotechs benefit from £100 million in Biomedical Catalyst funding

UK biotechs benefit from £100 million in Biomedical Catalyst funding

20-06-2014

UK biotech companies are leading the way to develop new therapies for cancer, Parkinson’s, diabetes…

BiotechnologyDavid Willetts MP , MinisterFinanceFinancialUK

UK NICE consults on draft guidance for Gilead’s hepatitis C drug Sovaldi

UK NICE consults on draft guidance for Gilead’s hepatitis C drug Sovaldi

16-06-2014

In draft recommendations published today, UK health care watchdog the National Institute for Health and…

Anti-viralsBiotechnologyGilead SciencesPricingRegulationSovaldiUK

Kymab strengthens management team with two senior appointments

Kymab strengthens management team with two senior appointments

03-06-2014

UK-based monoclonal antibody biopharmaceutical company Kymab has announced the appointment of Steve Arkinstall…

BiotechnologyBoardroomKymabPharmaceuticalUK

UK life sciences meeting agrees adaptive licensing is a golden opportunity

UK life sciences meeting agrees adaptive licensing is a golden opportunity

03-06-2014

Adaptive licensing is a “golden opportunity” to demonstrate the strength of life sciences in the…

Association of the British Pharmaceutical IndustryBiotechnologyLicensingPharmaceutical sciencesUK

Summit appoints Leopoldo Zambeletti as Non-Executive Director

Summit appoints Leopoldo Zambeletti as Non-Executive Director

30-05-2014

UK-based drug discovery and development company Summit has announced the appointment of Leopoldo Zambeletti…

BiotechnologyBoardroomSummit PharmaceuticalsUK

Genzyme gains UK NICE backing for second MS drug Lemtrada

Genzyme gains UK NICE backing for second MS drug Lemtrada

28-05-2014

The UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued final guidance…

AubagioBiotechnologyGenzymeLemtradaNeurologicalPricingRegulationSanofiUK

NICE draft guidance negative on Celgene’s Revlimid

20-05-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has today issued…

BiotechnologyCelgeneOncologyPricingRegulationRevlimidUK

BioTrinity 2014: UK life sciences raised $1 billion in record-breaking fundraising year

BioTrinity 2014: UK life sciences raised $1 billion in record-breaking fundraising year

13-05-2014

UK life sciences achieved a record breaking fundraising year in 2013, according to OBN chief executive…

BiotechnologyFinancialUK

Ario Pharma strengthens scientific advisory board with two key appointments

Ario Pharma strengthens scientific advisory board with two key appointments

12-05-2014

UK-based biopharmaceutical company Ario Pharma has announced the appointment of Professor Peter Barnes…

BiotechnologyBoardroomPharmaceuticalRespiratory and PulmonaryUK

1 to 25 of 56 results

Back to top